Sudan vs Zambia: Number of people requiring preventive treatment for lymphatic filariasis
Sudan
12.14 million people
in 2024
Zambia
13.19 million people
in 2021
Sudan rank
7th
Zambia rank
6th
Number of people requiring preventive treatment for lymphatic filariasis over time
- Sudan
- Zambia
How they compare
Zambia currently reports 13.19 million people against 12.14 million people in Sudan, a difference of 1.04 million people.
That makes Zambia's figure about 1.1 times Sudan's.
The two have swapped places 1 time across 9 shared years of data; in 2013 it was Sudan ahead.
Sudan ranks 7th and Zambia ranks 6th of 66 countries.
Across the 2 decades both report, Sudan averaged higher in 1 and Zambia in 1.
Head to head by decade
| Decade | Sudan | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 13.88 million people | 10.97 million people | 2.91 million people | Sudan |
| 2020s | 11.14 million people | 13.00 million people | 1.86 million people | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of people requiring preventive treatment for lymphatic filariasis, Sudan or Zambia?
- Zambia, at 13.19 million people against 12.14 million people in Sudan as of 2021.
- What is the difference in number of people requiring preventive treatment for lymphatic filariasis between Sudan and Zambia?
- 1.04 million people, with Zambia ahead.
- How many years of comparable data are there for Sudan and Zambia?
- 9 years are reported by both, from 2013 to 2021.
- How do Sudan and Zambia rank globally for number of people requiring preventive treatment for lymphatic filariasis?
- Sudan ranks 7th and Zambia ranks 6th of 66 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Number of people requiring preventive treatment for lymphatic filariasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Population requiring preventive chemotherapy for lymphatic filariasis.